Frequently Asked Questions About HUMIRA

Whether you have already started on HUMIRA or are considering it, here are some questions you may have. Take a look below to find some answers to frequently asked questions and discuss your treatment options with your doctor. For further assistance, call 1.800.4HUMIRA (1.800.448.6472).

*HUMIRA (adalimumab) is approved for the treatment of non-infectious intermediate, posterior, and panuveitis in adults and children 2 years of age and older.